首页|University of Leuven (KU Leuven) Reports Findings in Prostate Cancer (Functional Outcomes and Quality of Life in High-risk Prostate Cancer Patients Treated by R obot-assisted Radical Prostatectomy with or Without Adjuvant Treatments)
University of Leuven (KU Leuven) Reports Findings in Prostate Cancer (Functional Outcomes and Quality of Life in High-risk Prostate Cancer Patients Treated by R obot-assisted Radical Prostatectomy with or Without Adjuvant Treatments)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology-Prostate Ca ncer is the subject of a report. According to news reporting originating from Le uven, Belgium, by NewsRx correspondents, research stated, "Robotassisted laparo scopic prostatectomy (RALP) is used frequently to treat prostate cancer; yet, pr ospective data on the quality of life and functional outcomes are lacking. To as sess the quality of life and functional outcomes after radical prostatectomy in different risk groups with or without adjuvant treatments." Our news editors obtained a quote from the research from the University of Leuve n (KU Leuven), "The Be-RALP database is a prospective multicentre database that covers 9235 RALP cases from 2009 until 2016. Of these 9235 patients, 2336 high-r isk prostate cancer patients were matched with low/intermediaterisk prostate ca ncer patients. Patients were treated with RALP only or followed by radiotherapy and/or hormone treatment. We used a mixed-model analysis to longitudinally analy se quality of life, urinary function, and erectile function between risk groups with or without additional treatments. Risk group was not significant in predict ing quality of life, erectile function, or urinary function after RALP. Postoper ative treatment (hormone and/or radiotherapy treatment) was significant in predi cting International Index of Erectile Function (IIEF-5), sexual activity, and se xual functioning. Risk group was not linked with clinically relevant declines in functional outcomes after RALP. The observed functional outcomes and quality of life are in favour of considering RALP for high-risk prostate cancer. Postopera tive treatment resulted in lower erectile function measures without clinically r elevant changes in quality of life and urinary functions. Hormone therapy seems to have the most prominent negative effects on these outcomes. This study invest igated the quality of life, and urinary and erectile function in patients with a ggressive and less aggressive prostate cancer after surgery only or in combinati on with hormones or radiation. We found that quality of life recovers completely , while erectile and urinary function recovers only partially after surgery."
LeuvenBelgiumEuropeCancerDrugs a nd TherapiesEmerging TechnologiesHealth and MedicineHormonesMachine Lear ningMale Urologic Surgical ProceduresMen's HealthOncologyProstate CancerProstatectomyProstatic NeoplasmsQuality of LifeRadiotherapyRobotRobo ticsSurgery
NETL
NSTL
